News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,477 Results
Type
Article (47466)
Company Profile (265)
Press Release (684745)
Multimedia
Podcasts (89)
Webinars (14)
Section
Business (210618)
Career Advice (2576)
Deals (36324)
Drug Delivery (110)
Drug Development (83890)
Employer Resources (184)
FDA (16810)
Job Trends (15444)
News (357151)
Policy (34226)
Tag
Academia (2774)
Accelerated approval (11)
Adcomms (27)
Allergies (99)
Alliances (52819)
ALS (117)
Alzheimer's disease (1489)
Antibody-drug conjugate (ADC) (174)
Approvals (16781)
Artificial intelligence (337)
Autoimmune disease (29)
Automation (19)
Bankruptcy (376)
Best Places to Work (12005)
BIOSECURE Act (21)
Biosimilars (129)
Biotechnology (182)
Bladder cancer (99)
Brain cancer (37)
Breast cancer (372)
Cancer (2970)
Cardiovascular disease (224)
Career advice (2150)
Career pathing (33)
CAR-T (197)
CDC (37)
Cell therapy (528)
Cervical cancer (23)
Clinical research (68965)
Collaboration (1078)
Company closure (3)
Compensation (691)
Complete response letters (26)
COVID-19 (2752)
CRISPR (62)
C-suite (346)
Cystic fibrosis (117)
Data (3051)
Decentralized trials (2)
Denatured (32)
Depression (68)
Diabetes (367)
Diagnostics (6622)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (48)
Drug discovery (143)
Drug pricing (138)
Drug shortages (31)
Duchenne muscular dystrophy (136)
Earnings (88045)
Editorial (44)
Employer branding (22)
Employer resources (160)
Events (115918)
Executive appointments (878)
FDA (18511)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (975)
Gene editing (140)
Generative AI (27)
Gene therapy (403)
GLP-1 (849)
Government (4792)
Grass and pollen (5)
Guidances (182)
Healthcare (19632)
HIV (43)
Huntington's disease (30)
IgA nephropathy (40)
Immunology and inflammation (162)
Immuno-oncology (10)
Indications (39)
Infectious disease (2936)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (66)
Intellectual property (124)
Interviews (437)
IPO (16820)
IRA (50)
Job creations (3829)
Job search strategy (1811)
Kidney cancer (13)
Labor market (53)
Layoffs (517)
Leadership (26)
Legal (8386)
Liver cancer (81)
Longevity (12)
Lung cancer (417)
Lymphoma (212)
Machine learning (11)
Management (63)
Manufacturing (409)
MASH (96)
Medical device (13933)
Medtech (13938)
Mergers & acquisitions (20229)
Metabolic disorders (902)
Multiple sclerosis (102)
NASH (23)
Neurodegenerative disease (124)
Neuropsychiatric disorders (38)
Neuroscience (2209)
NextGen: Class of 2025 (6865)
Non-profit (4751)
Now hiring (48)
Obesity (454)
Opinion (254)
Ovarian cancer (103)
Pain (116)
Pancreatic cancer (122)
Parkinson's disease (192)
Partnered (24)
Patents (307)
Patient recruitment (172)
Peanut (51)
People (59478)
Pharmaceutical (68)
Pharmacy benefit managers (24)
Phase I (21478)
Phase II (30341)
Phase III (22571)
Pipeline (1671)
Policy (223)
Postmarket research (2726)
Preclinical (9157)
Press Release (68)
Prostate cancer (143)
Psychedelics (40)
Radiopharmaceuticals (256)
Rare diseases (488)
Real estate (6166)
Recruiting (70)
Regulatory (23663)
Reports (52)
Research institute (2479)
Resumes & cover letters (427)
Rett syndrome (9)
RNA editing (9)
RSV (53)
Schizophrenia (93)
Series A (168)
Series B (114)
Service/supplier (12)
Sickle cell disease (64)
Special edition (21)
Spinal muscular atrophy (155)
Sponsored (34)
Startups (3763)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (64)
The Weekly (55)
Vaccines (842)
Venture capital (55)
Weight loss (287)
Women's health (48)
Worklife (19)
Date
Today (85)
Last 7 days (360)
Last 30 days (1856)
Last 365 days (31898)
2025 (17364)
2024 (36012)
2023 (40933)
2022 (52114)
2021 (56728)
2020 (55510)
2019 (48394)
2018 (36555)
2017 (33414)
2016 (32996)
2015 (38952)
2014 (32760)
2013 (27898)
2012 (30093)
2011 (30767)
2010 (29050)
Location
Africa (839)
Alabama (62)
Alaska (7)
Arizona (250)
Arkansas (14)
Asia (40434)
Australia (6732)
California (7529)
Canada (2396)
China (691)
Colorado (327)
Connecticut (328)
Delaware (193)
Europe (89211)
Florida (1132)
Georgia (259)
Hawaii (1)
Idaho (61)
Illinois (659)
India (28)
Indiana (371)
Iowa (17)
Japan (231)
Kansas (112)
Kentucky (31)
Louisiana (14)
Maine (71)
Maryland (1057)
Massachusetts (5642)
Michigan (247)
Minnesota (465)
Mississippi (3)
Missouri (91)
Montana (28)
Nebraska (25)
Nevada (82)
New Hampshire (68)
New Jersey (2106)
New Mexico (30)
New York (2125)
North Carolina (1122)
North Dakota (9)
Northern California (3308)
Ohio (242)
Oklahoma (16)
Oregon (34)
Pennsylvania (1624)
Puerto Rico (17)
Rhode Island (36)
South America (1213)
South Carolina (35)
South Dakota (1)
Southern California (2818)
Tennessee (127)
Texas (1147)
United States (28092)
Utah (225)
Virginia (188)
Washington D.C. (74)
Washington State (652)
West Virginia (4)
Wisconsin (68)
732,477 Results for "quintilesims quintiles inc merged with ims".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evestia Clinical to merge with Atlantic Research Group
July 16, 2025
·
5 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Press Releases
BioSig Enters into an LOI to Merge with Streamex Exchange Corp.
May 6, 2025
·
4 min read
Legal
BioNTech Attacked CureVac’s ‘Failed’ COVID Vaccine Program. The Rivals Are Now Merging
BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to bring to market any product to help in the fight against COVID-19.” Now, the mRNA biotech is buying that very company.
June 18, 2025
·
4 min read
·
Nick Paul Taylor
Press Releases
Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250
June 16, 2025
·
1 min read
Press Releases
Patricia Industries’ subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
March 19, 2025
·
5 min read
Press Releases
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
June 2, 2025
·
2 min read
Press Releases
BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives
May 6, 2025
·
5 min read
Press Releases
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry
March 12, 2025
·
7 min read
Deals
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.
March 20, 2024
·
2 min read
1 of 73,248
Next
